相似文献
1
'Tackling cancer in the EU: the role of innovation'.
Mol Oncol. 2009 Feb;3(1):18-23. doi: 10.1016/j.molonc.2008.12.003. Epub 2008 Dec 25.
2
Into the valley of death: research to innovation.
Drug Discov Today. 2013 Jul;18(13-14):610-3. doi: 10.1016/j.drudis.2013.01.012. Epub 2013 Feb 9.
3
A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Forsch Komplementmed. 2014;21(2):e1-16. doi: 10.1159/000360744. Epub 2014 Mar 24.
4
[Transboundary research and development in Europe: the EU Scientific Panel for Health].
Dtsch Med Wochenschr. 2015 Feb;140(3):155. doi: 10.1055/s-0041-100279. Epub 2015 Feb 6.
5
Reflections on different governance styles in regulating science: a contribution to 'Responsible Research and Innovation'.
Life Sci Soc Policy. 2015;11:8. doi: 10.1186/s40504-015-0026-y. Epub 2015 Aug 11.
6
Healthy bi-regional connection: The EU-LAC Health initiative has promoted equitable and collaborative health research and innovation.
Health Res Policy Syst. 2018 Nov 23;16(1):114. doi: 10.1186/s12961-018-0390-1.
7
Exploring the Nutrition and Health Claims Regulation (EC) No. 1924/2006: What is the impact on innovation in the EU food sector?
Int J Food Sci Nutr. 2017 Feb;68(1):10-17. doi: 10.1080/09637486.2016.1212818. Epub 2016 Aug 2.
8
Strategies for innovation and interdisciplinary translational research: research and career benefits and barriers.
J Investig Med. 2009 Feb;57(2):477-81. doi: 10.2310/JIM.0b013e31819824be.
9
Report on EU-USA workshop: how systems biology can advance cancer research (27 October 2008).
Mol Oncol. 2009 Feb;3(1):9-17. doi: 10.1016/j.molonc.2008.11.003. Epub 2008 Dec 9.
10
EU regulation could harm cancer research.
Lancet Oncol. 2014 Sep;15(10):e421. doi: 10.1016/s1470-2045(14)70367-5.
引用本文的文献
1
Challenging the heterogeneity of disease presentation in malignant melanoma-impact on patient treatment.
Cell Biol Toxicol. 2019 Feb;35(1):1-14. doi: 10.1007/s10565-018-9446-9. Epub 2018 Oct 24.
2
The role of funding and policies on innovation in cancer drug development.
Ecancermedicalscience. 2010;4:164. doi: 10.3332/ecancer.2010.164. Epub 2010 Feb 3.
本文引用的文献
1
Turning the Stockholm Declaration into reality: Creating a world-class infrastructure for cancer research in Europe.
Mol Oncol. 2009 Feb;3(1):5-8. doi: 10.1016/j.molonc.2008.11.001. Epub 2008 Nov 17.
2
The Stockholm declaration.
Mol Oncol. 2008 Jun;2(1):10-1. doi: 10.1016/j.molonc.2008.03.004. Epub 2008 Mar 21.
3
Returns on research and development for 1990s new drug introductions.
Pharmacoeconomics. 2002;20 Suppl 3:11-29. doi: 10.2165/00019053-200220003-00002.
Zotero 插件